Translational activating RNAs for SYNGAP1 deficiency treatment
Introducing translation-activating RNAs (taRNAs) as a novel gene therapy for SYNGAP1 deficiency, offering a targeted approach to treat developmental delay, epilepsy, and autism by upregulating gene expression selectively...